BioCentury | Apr 15, 2013
Clinical News

LXN regulatory update

...The test received FDA marketing clearance in June. LXN expects marketing launch by year end. LXN Corp....
BioCentury | Jun 12, 2000
Clinical News

Glucose and fructosamine monitor regulatory update

...with LXN's GlucoProtein fructosamine (glycated protein) test for use in diabetes patients. (Clinical results, B11) LXN Corp....
BioCentury | Jun 12, 2000
Clinical News

GlucoProtein test: Marketed

...not statistically significant. Data were presented at the American Diabetes Association meeting in San Antonio. LXN Corp....
BioCentury | Jun 5, 2000
Company News

LXN management update

LXN Corp. , San Diego, Calif. Business: Diagnostics/Imaging Hired: Jeffrey McKnight as VP of sales, formerly business manager for Roche Diagnostic Systems Inc.; and Lowry Messenger as VP of R&D, formerly director of new products in...
BioCentury | Oct 4, 1999
Clinical News

Rapid result glucose monitor regulatory update

...The FDA granted marketing clearance for LXN's pager-sized rapid result glucose monitor. LXN Corp. , San Diego...
BioCentury | Aug 16, 1999
Clinical News

In Charge Diabetes Control System regulatory update

...The FDA granted marketing clearance for LXN’s In Charge Diabetes Control System, a hand-held monitor that...
...performs tests for blood glucose and glycated protein (fructosamine), a measure of overall diabetes control. LXN...
BioCentury | Jul 27, 1998
Clinical News

LXN regulatory update

...5,762,871 covering a multi-layer test device that measures glucose and fructosamine in diabetic blood samples. LXN Corp....
BioCentury | Dec 15, 1997
Clinical News

LXN regulatory update

...system that uses fingerstick tests to measure both blood glucose and glycated protein in diabetics. LXN Corp....
BioCentury | Dec 8, 1997
Clinical News

LXN regulatory update

...be available in January as self-tests for diabetics and as a point-of-care tool for practitioners. LXN Corp....
BioCentury | Jun 23, 1997
Clinical News

LXN regulatory update

...the test. The test involves colorimetric detection of fructosamine levels in a fingerstick blood sample. LXN...
...level in a diabetic patient over the preceding two to three week period, LXN said. LXN Corp....
Items per page:
1 - 10 of 10
BioCentury | Apr 15, 2013
Clinical News

LXN regulatory update

...The test received FDA marketing clearance in June. LXN expects marketing launch by year end. LXN Corp....
BioCentury | Jun 12, 2000
Clinical News

Glucose and fructosamine monitor regulatory update

...with LXN's GlucoProtein fructosamine (glycated protein) test for use in diabetes patients. (Clinical results, B11) LXN Corp....
BioCentury | Jun 12, 2000
Clinical News

GlucoProtein test: Marketed

...not statistically significant. Data were presented at the American Diabetes Association meeting in San Antonio. LXN Corp....
BioCentury | Jun 5, 2000
Company News

LXN management update

LXN Corp. , San Diego, Calif. Business: Diagnostics/Imaging Hired: Jeffrey McKnight as VP of sales, formerly business manager for Roche Diagnostic Systems Inc.; and Lowry Messenger as VP of R&D, formerly director of new products in...
BioCentury | Oct 4, 1999
Clinical News

Rapid result glucose monitor regulatory update

...The FDA granted marketing clearance for LXN's pager-sized rapid result glucose monitor. LXN Corp. , San Diego...
BioCentury | Aug 16, 1999
Clinical News

In Charge Diabetes Control System regulatory update

...The FDA granted marketing clearance for LXN’s In Charge Diabetes Control System, a hand-held monitor that...
...performs tests for blood glucose and glycated protein (fructosamine), a measure of overall diabetes control. LXN...
BioCentury | Jul 27, 1998
Clinical News

LXN regulatory update

...5,762,871 covering a multi-layer test device that measures glucose and fructosamine in diabetic blood samples. LXN Corp....
BioCentury | Dec 15, 1997
Clinical News

LXN regulatory update

...system that uses fingerstick tests to measure both blood glucose and glycated protein in diabetics. LXN Corp....
BioCentury | Dec 8, 1997
Clinical News

LXN regulatory update

...be available in January as self-tests for diabetics and as a point-of-care tool for practitioners. LXN Corp....
BioCentury | Jun 23, 1997
Clinical News

LXN regulatory update

...the test. The test involves colorimetric detection of fructosamine levels in a fingerstick blood sample. LXN...
...level in a diabetic patient over the preceding two to three week period, LXN said. LXN Corp....
Items per page:
1 - 10 of 10